VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RNAAtrium Therapeutics, Inc.
$13.24$226M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRNAQuarterly Financials

Atrium Therapeutics, Inc. (RNA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Atrium Therapeutics, Inc. (RNA) quarterly income statement — complete revenue, gross profit & net income history

RNA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue19.64M859K12.47M3.85M1.57M2.97M2.34M2.04M3.54M2.19M2.82M2.32M2.23M2.77M2.48M2.18M1.79M1.85M2.16M2.61M
Revenue Growth %1148.25%-71.11%434.03%88.12%-55.6%35.57%-17.1%-11.7%58.67%-20.8%13.54%6.34%24.4%49.51%14.75%-16.46%-33.62%-13.54%23.88%69.18%
Cost of Goods Sold151K00138.13M000687K641K615K47.71M42.67M47.77M45.61M37.32M39.79M27.69M32.97M24.83M22.71M
COGS % of Revenue0.77%--3590.46%---33.59%18.09%28.04%1693.19%1842.49%2139.05%1647.16%1503.51%1826.86%1542.51%1780.13%1147.99%870.96%
Gross Profit19.48M859K12.47M-134.28M1.57M2.97M2.34M1.36M2.9M1.58M-44.9M-40.36M-45.53M-42.84M-34.84M-37.61M-25.89M-31.12M-22.67M-20.1M
Gross Margin %99.23%100%100%-3490.46%100%100%100%66.41%81.91%71.96%-1593.19%-1742.49%-2039.05%-1547.16%-1403.51%-1726.86%-1442.51%-1680.13%-1047.99%-770.96%
Gross Profit Growth %1138.65%-71.11%434.03%-9987.92%-45.8%88.4%105.2%103.37%106.37%103.68%-28.88%-7.3%-75.85%-37.68%-53.67%-87.13%-44.07%-171.12%-194.05%-1404.28%
Operating Expenses36.76M48.89M201.28M36.86M133.09M123.96M100.47M83.98M80.09M68.32M13.73M12.28M12.06M10.38M10.09M8.69M8.57M7.43M6.61M6.27M
OpEx % of Revenue187.24%5691.97%1613.47%958.25%8460.9%4169.63%4300.94%4106.8%2260.49%3115.41%487.19%530.14%540.26%375.01%406.69%398.9%477.27%401.24%305.69%240.43%
Selling, General & Admin20.11M30.4M46.33M36.86M33.6M28.34M23.27M20.73M13.26M15.5M13.73M12.28M12.06M10.38M10.09M8.69M8.57M7.43M6.61M6.27M
SG&A % of Revenue102.4%3538.65%371.41%958.25%2136.05%953.18%996.28%1013.74%374.17%706.98%487.19%530.14%540.26%375.01%406.69%398.9%477.27%401.24%305.69%240.43%
Research & Development16.66M18.5M154.95M138.13M99.49M95.63M77.2M63.94M66.83M52.82M47.71M42.67M47.77M45.61M37.32M39.79M27.69M32.97M24.83M22.71M
R&D % of Revenue84.83%2153.32%1242.07%3590.46%6324.86%3216.45%3304.67%3126.65%1886.31%2408.44%1693.19%1842.49%2139.05%1647.16%1503.51%1826.86%1542.51%1780.13%1147.99%870.96%
Other Operating Expenses000-1000K000-687K00-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-17.28M-48.03M-188.81M-171.14M-131.52M-120.99M-98.13M-82.63M-77.19M-66.74M-58.63M-52.63M-57.6M-53.23M-44.93M-46.3M-34.46M-38.55M-29.28M-26.37M
Operating Margin %-88.01%-5591.97%-1513.47%-4448.71%-8360.9%-4069.63%-4200.94%-4040.39%-2178.58%-3043.46%-2080.38%-2272.63%-2579.31%-1922.17%-1810.19%-2125.76%-1919.78%-2081.37%-1353.68%-1011.39%
Operating Income Growth %86.86%60.3%-92.4%-107.13%-70.39%-81.28%-67.39%-56.98%-34.01%-25.4%-30.48%-13.68%-67.14%-38.08%-53.45%-75.59%-44.44%-136.59%-155.36%-154.31%
EBITDA-17.13M-47.91M-187.75M-170.33M-130.73M-120.25M-97.42M-81.94M-76.55M-66.13M-58.06M-52.1M-57.2M-52.84M-44.56M-45.98M-34.15M-38.34M-29.1M-26.22M
EBITDA Margin %-87.24%-5577.76%-1505.01%-4427.55%-8311%-4044.8%-4170.55%-4006.8%-2160.49%-3015.41%-2060.29%-2249.78%-2561.8%-1908.41%-1795.29%-2110.97%-1902.28%-2070.14%-1345.54%-1005.75%
EBITDA Growth %86.9%60.16%-92.71%-107.87%-70.79%-81.85%-67.8%-57.26%-33.81%-25.14%-30.3%-13.33%-67.53%-37.83%-53.1%-75.35%-43.78%-136.98%-156.08%-154.71%
D&A (Non-Cash Add-back)151K122K1.06M814K785K738K710K687K641K615K566K529K391K381K370K322K314K208K176K147K
EBIT-17.28M-48.03M-174.44M-171.14M-131.52M-120.99M-98.13M-82.63M-77.19M-66.74M-58.63M-52.63M-57.6M-53.23M-44.93M-46.3M-34.46M-38.55M-29.28M-26.37M
Net Interest Income0014.74M14.48M16.18M18.53M17.97M11.95M8.43M6.41M6.28M5.77M5.52M2.77M1.34M611K250K55K17K16K
Interest Income0014.74M14.48M16.18M18.53M17.97M11.95M8.43M6.41M6.28M5.77M5.52M2.77M1.34M611K250K55K17K16K
Interest Expense00000000000000000000
Other Income/Expense647K014.36M13.83M15.74M18.73M17.74M11.83M8.33M6.3M6.27M5.61M5.2M2.75M1.33M609K225K9K6K14K
Pretax Income-16.63M-48.03M-174.44M-157.31M-115.77M-102.26M-80.4M-70.79M-68.86M-60.44M-52.36M-47.02M-52.39M-50.47M-43.6M-45.69M-34.23M-38.54M-29.27M-26.35M
Pretax Margin %-84.71%-5591.97%-1398.33%-4089.29%-7360.01%-3439.52%-3441.7%-3461.76%-1943.41%-2756.18%-1857.98%-2030.44%-2346.35%-1822.72%-1756.61%-2097.8%-1907.24%-2080.89%-1353.4%-1010.86%
Income Tax034K000000000000000000
Effective Tax Rate %0%-0.07%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-16.63M-48.07M-174.44M-157.31M-115.77M-102.26M-80.4M-70.79M-68.86M-60.44M-52.36M-47.02M-52.39M-50.47M-43.6M-45.69M-34.23M-38.54M-29.27M-26.35M
Net Margin %-84.71%-5595.93%-1398.33%-4089.29%-7360.01%-3439.52%-3441.7%-3461.76%-1943.41%-2756.18%-1857.98%-2030.44%-2346.35%-1822.72%-1756.61%-2097.8%-1907.24%-2080.89%-1353.4%-1010.86%
Net Income Growth %85.63%52.99%-116.97%-122.22%-68.14%-69.18%-53.55%-50.54%-31.42%-19.76%-20.09%-2.92%-53.04%-30.96%-48.93%-73.38%-43.58%-136.79%-155.91%-149.65%
Net Income (Continuing)-16.63M-48.07M-174.44M-157.31M-115.77M-102.26M-80.4M-70.79M-68.86M-60.44M-52.36M-47.02M-52.39M-50.47M-43.6M-45.69M-34.23M-38.54M-29.27M-26.35M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.97-1.70-1.27-1.21-0.90-0.80-0.65-0.66-0.79-0.79-0.71-0.66-0.67-0.83-0.80-0.92-0.70-1.63-0.68-0.70
EPS Growth %-7.78%-112.5%-95.38%-83.33%-13.92%-1.27%8.45%0%-17.91%4.82%11.25%28.26%4.29%49.08%-17.65%-31.43%-9.38%-279.07%-119.35%43.09%
EPS (Basic)-0.97-1.70-1.27-1.21-0.90-0.80-0.65-0.66-0.79-0.79-0.71-0.66-0.67-0.83-0.80-0.92-0.71-1.63-0.68-0.70
Diluted Shares Outstanding17.11M17.11M137.9M129.62M129.23M128.5M123.38M106.93M87.21M76.05M74.1M71.39M70.43M57.3M53.07M49.93M48.25M23.61M43.27M37.58M
Basic Shares Outstanding17.11M17.11M137.9M129.62M129.23M128.5M123.38M106.93M87.21M76.05M74.1M71.39M70.43M57.3M53.07M49.93M48.22M23.61M43.05M37.58M
Dividend Payout Ratio--------------------